Ensayo clínico en reclutamiento = ; Ensayos clínico en curso = ; Financiado por un miembro del IRDiRC = ; Miembro de una ERN =

Ensayo(s) clínico(s) nacional(es)

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

PASSPORT: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants With Progressive Supranuclear Palsy (Phase 2) - AT

Institution: Information not provided - AT

Para más detalles

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

RIVA-PSP : Efficacy of Rivastigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy: A Randomised Double Blind Placebo-controlled Clinical Trial (Phase III)

CHU de Marseille - Hôpital de la Timone

Service de Neurologie, pathologie du mouvement

Para más detalles

Ensayo(s) clínico(s) multinacional(es)

ESTADOS UNIDOS

California
SAN FRANCISCO

Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy - coordination - terminated

University of California, San Francisco

Memory and Aging Center

Para más detalles

REINO UNIDO (EL)

Berkshire
MAIDENHEAD

PASSPORT: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BMS-986168 in Participants with Progressive Supranuclear Palsy

Biogen Idec Limited

Para más detalles

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

A Participant-Blind, Investigator-Blind, Placebo-Controlled, Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)

UCB Biopharma SPRL

Para más detalles